Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.

× No keyword cloud information.

5 in total

1. Fatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis.

Authors: Yoann Pointreau; Scott P Commins; Gilles Calais; Hervé Watier; Thomas A E Platts-Mills
Journal: J Clin Oncol Date: 2011-12-12 Impact factor: 44.544

Review 2. GD2-targeted immunotherapy and radioimmunotherapy.

Authors: Konstantin Dobrenkov; Nai-Kong V Cheung
Journal: Semin Oncol Date: 2014-07-21 Impact factor: 4.929

3. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.

Authors: Benoît Dupont; Delphine Mariotte; Audrey E Dugué; Bénédicte Clarisse; Jean-Michel Grellard; Emmanuel Babin; Bruno Chauffert; Stéphanie Dakpé; Cristian Moldovan; Karine Bouhier-Leporrier; Jean-Marie Reimund; Frederic Di Fiore; Sylvie Zanetta; Audrey Mailliez; Pascal Do; Annie Peytier; Marie-Pierre Galais; Carmen Florescu; Roland Schott; Brigitte Le Mauff; Radj Gervais
Journal: Br J Clin Pharmacol Date: 2016-10-24 Impact factor: 4.335

4. Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test.

Authors: Benoît Dupont; Delphine Mariotte; Cristian Moldovan; Jean-Michel Grellard; Marie-Claude Vergnaud; Dominique Laroche; Radj Gervais
Journal: Clin Med Insights Oncol Date: 2014-07-06

5. Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.

Authors: Satoshi Dote; Shoji Itakura; Kohei Kamei; Daiki Hira; Satoshi Noda; Yuka Kobayashi; Tomohiro Terada
Journal: BMC Cancer Date: 2018-10-05 Impact factor: 4.430

5 in total